Search Results - "Swellam, Menha"

Refine Results
  1. 1

    Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform by Swellam, Menha, Ezz El Arab, Lobna, Al-Posttany, Amr S., B. Said, Samy

    Published in Journal of neuro-oncology (01-09-2019)
    “…Background and aim Glioblastoma multiform (GBM); most fatal brain cancer, is incurable with molecular diversity hence identification of molecular targets that…”
    Get full text
    Journal Article
  2. 2

    Clinical impact of PTEN methylation status as a prognostic marker for breast cancer by Ramadan, Amal, Hashim, Maha, Abouzid, Amr, Swellam, Menha

    “…Background Aberrant DNA methylation of phosphatase and tensin homolog (PTEN) gene has been found in many cancers. The object of this study was to evaluate the…”
    Get full text
    Journal Article
  3. 3

    Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis by Swellam, Menha, Bakr, Noha M., El Magdoub, Hekmat M., Hamza, Marwa S., Ezz El Arab, Lobna R.

    Published in Journal of molecular neuroscience (01-04-2021)
    “…Serum miRNAs (miRs) have gained consideration as encouraging molecular markers for cancer diagnosis and prediction of prognosis. The authors aimed to identify…”
    Get full text
    Journal Article
  4. 4

    Pomegranate juice and punicalagin-mediated chemoprevention of hepatocellular carcinogenesis via regulating miR-21 and NF-κB-p65 in a rat model by Hussein, Aya M., El-Beih, Nadia M., Swellam, Menha, El-Hussieny, Enas A.

    Published in Cancer cell international (02-11-2022)
    “…Abstract Background Hepatocellular carcinoma (HCC) is the most common neoplasm among primary liver malignancies, accounting for 70%–85% of total liver cancer…”
    Get full text
    Journal Article
  5. 5

    Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes by Bakr, Noha M, Mahmoud, Magda Sayed, Nabil, Reem, Boushnak, Hussein, Swellam, Menha

    “…Background Breast cancer (BC) is the common primary tumor among females. Hence, there is an urgent need to improve the early prediction and diagnosis of BC…”
    Get full text
    Journal Article
  6. 6

    Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma by Mahmoud, Magda Sayed, Khalifa, Mohamed K, Nageeb, Amira M, El-Arab, Lobna R. Ezz, El-Mahdy, Manal, Ramadan, Amal, Hashim, Maha

    Published in Egyptian Journal of Medical Human Genetics (01-12-2024)
    “…Background Impact of Isocitrate dehydrogenase1 (IDH1) and O6-methylguanine-DNA methyltransferase (MGMT) in glioblastoma (GBM) have been of great interest due…”
    Get full text
    Journal Article
  7. 7

    Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay by Swellam, Menha, Saad, Entsar A, Sabry, Shimaa, Denewer, Adel, Abdel Malak, Camelia, Abouzid, Amr

    “…Background Diagnosis of breast cancer is more complicated due to lack of minimal invasive biomarker with sufficient precision. DNA methylation is a promising…”
    Get full text
    Journal Article
  8. 8

    Cytotoxic effect of ferrimagnetic glass-ceramic nanocomposites on bone osteosarcoma cells by Gamal-Eldeen, Amira M, Abdel-Hameed, Salwa A.M, El-Daly, Sherien M, Abo-Zeid, Mona A.M, Swellam, Menha M

    Published in Biomedicine & pharmacotherapy (01-04-2017)
    “…Abstract This work pointed out the anti-cancer effect of ferrimagnetic glass ceramic nanocomposites (CaO-ZnO-Fe2 O3 -SiO2 ), which contain high amount of…”
    Get full text
    Journal Article
  9. 9

    Implications of targeted next-generation sequencing for bladder cancer: report of four cases by Khalifa, Mohamed K, Bakr, Noha M, Ramadan, Amal, Abd Elwahab, Khaled M, Desoky, Esam, Nageeb, Amira M, Swellam, Menha

    “…Background Bladder cancer is considered heterogeneous diseases with two major subgroups: non-muscle- invasive bladder cancer (NMIBC) and muscle invasive…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors by Eissa, Sanaa, Swellam, Menha, Sadek, M, Mourad, M Sherif, El Ahmady, O, Khalifa, A

    Published in The Journal of urology (01-08-2002)
    “…We evaluate the diagnostic efficacy of nuclear matrix protein-22 (NMP22, Matritech, Newton, Massachusetts), fibronectin and urinary bladder cancer antigen…”
    Get more information
    Journal Article
  12. 12

    Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia by Swellam, Menha, El-Khazragy, Nashwa

    Published in Tumor biology (01-08-2016)
    “…Aberrant microRNA (miRNA) expression participates in childhood acute lymphoblastic leukemia (ALL). This study aimed to investigate the expression of miRNA-100,…”
    Get full text
    Journal Article
  13. 13

    Expression of MiR-335 and its target metalloproteinase genes: clinical significance in breast cancer by Ramadan, Amal, Hashim, Maha, M. Hassan, Naglaa, Swellam, Menha

    Published in Archives of physiology and biochemistry (04-05-2022)
    “…Early diagnosis of breast cancer decreases mortality rate; therefore, novel diagnostic methods are urgently required. In this study, authors aimed to…”
    Get full text
    Journal Article
  14. 14

    Long non-coding RNAs BACE1-AS and BC200 in multiple sclerosis and their relation to cognitive function: A gene expression analysis by Kamal, Ahmed, Swellam, Menha, M. Shalaby, Nevin, Darwish, Marwa K., M. El-Nahrery, Eslam

    Published in Brain research (01-09-2023)
    “…[Display omitted] •BACE1-AS and BC200 were overexpressed in Multiple Sclerosis (MS) patients.•Higher expression was observed in MS patients with cognitive…”
    Get full text
    Journal Article
  15. 15

    Clinical role of MiRNA 29a and MiRNA 335 on breast cancer management: their relevance to MMP2 protein level by Ali Ahmed, Elham, Abd El-Basit, Sohir A., Mohamed, Mona A., Swellam, Menha

    Published in Archives of physiology and biochemistry (04-07-2022)
    “…Circulating miRNAs are novel biomarkers, authors aimed to investigate the expression level of miR-29a and miR-335 and their relevance to CEA, CA15.3, and…”
    Get full text
    Journal Article
  16. 16

    miRNA‐155 and miRNA‐181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia by El‐Khazragy, Nashwa, Noshi, Mohamed Ahmed, Abdel‐Malak, Camelia, Zahran, Rasha F., Swellam, Menha

    Published in Journal of cellular biochemistry (01-04-2019)
    “…Mortality rates of acute lymphoblastic leukemia (ALL) have improved over the past 20 years; however, a significant portion of deaths stems from the lack of…”
    Get full text
    Journal Article
  17. 17

    Potential Role of Gene Methylation in Diagnosis of Patients With Breast Cancer by Mohamed El-Far, Mohamed A Abdelrazek, Basma M Foda, Amr Abouzid, Menha Swellam

    Published in Clinical Medicine Insights. Oncology (01-10-2024)
    “…Background: In addition to the great challenge of early diagnosis and prognosis in breast cancer (BC), the role of gene promoters in BC remains largely…”
    Get full text
    Journal Article
  18. 18

    Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM) by Amer, Rehab G., Ezz El Arab, Lobna R., Abd El Ghany, Dalia, Saad, Amr S., Bahie-Eldin, Nermean, Swellam, Menha

    Published in Journal of neuro-oncology (01-07-2022)
    “…Background and aim Glioblastoma multiforme (GBM) is primary brain tumor grade IV characterized by fast cell proliferation, high mortality and morbidity and…”
    Get full text
    Journal Article
  19. 19

    Clinical aspects of circulating miRNA‐335 in breast cancer patients: A prospective study by Swellam, Menha, Mahmoud, Magda Sayed, Hashim, Maha, Hassan, Naglaa M, Sobeih, Mohamed Emam, Nageeb, Amira M

    Published in Journal of cellular biochemistry (01-06-2019)
    “…Background The impact of aberrant expression of miRNAs, small noncoding RNAs of 19 to 23 nucleotide, has been reported in different types of cancer, such as…”
    Get full text
    Journal Article
  20. 20

    Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma by Ebid, Osama Abd El Hameed, Ezz El Arab, Lobna R., Saad, Amr S., Ezz El Din, Mai, Mostafa, Nermeen, Swellam, Menha

    Published in Annals of hematology (01-12-2023)
    “…Diffuse large B cell lymphoma (DLBCL) is the most common subtype of lymphoma. It is a highly heterogeneous lymphoid neoplasm, with variations in gene…”
    Get full text
    Journal Article